Correlation Between Sigilon Therapeutics and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both Sigilon Therapeutics and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sigilon Therapeutics and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sigilon Therapeutics and Virax Biolabs Group, you can compare the effects of market volatilities on Sigilon Therapeutics and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sigilon Therapeutics with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sigilon Therapeutics and Virax Biolabs.
Diversification Opportunities for Sigilon Therapeutics and Virax Biolabs
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Sigilon and Virax is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Sigilon Therapeutics and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Sigilon Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sigilon Therapeutics are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Sigilon Therapeutics i.e., Sigilon Therapeutics and Virax Biolabs go up and down completely randomly.
Pair Corralation between Sigilon Therapeutics and Virax Biolabs
If you would invest 1,070 in Virax Biolabs Group on November 27, 2024 and sell it today you would lose (883.00) from holding Virax Biolabs Group or give up 82.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Sigilon Therapeutics vs. Virax Biolabs Group
Performance |
| Timeline |
| Sigilon Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
| Virax Biolabs Group |
Sigilon Therapeutics and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sigilon Therapeutics and Virax Biolabs
The main advantage of trading using opposite Sigilon Therapeutics and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sigilon Therapeutics position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| Sigilon Therapeutics vs. Reviva Pharmaceuticals Holdings | Sigilon Therapeutics vs. ZyVersa Therapeutics | Sigilon Therapeutics vs. Unicycive Therapeutics | Sigilon Therapeutics vs. Apollomics Class A |
| Virax Biolabs vs. Beam Therapeutics | Virax Biolabs vs. Editas Medicine | Virax Biolabs vs. Caribou Biosciences | Virax Biolabs vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |